Table 2.

End of therapy outcomes

Outcome	All Patients (n = 94)
Length of stay, days^{a, b}	9 [5–17]
Clinical cure, n (%)	80 (85.1)
Mortality, n (%)	5 (5.3)
B. melitensis antibody titer^{a, c}	1:320 1:320–1:640
B. melitensis antibody titer < 1:320, n (%)^c	28 (29.8)
B. abortus antibody titer^{a, c}	1:320 1:160–1:640
B. abortus antibody titer < 1:320, n (%)^c	33 (35.1)
Temperature, °C^a	36.7 [36.5–36.9]
white blood cells count, cells/mm³	6.2 ± 3.4
C-reactive protein, mg/L^a	3.2 [3.1–3.3]
erythrocyte sedimentation rate, mm/hr^a	8 [5–22]

Data are presented as mean ± SD unless specified otherwise

^a Median [IQR]

^b Data for hospitalized patients only

^c Only 63 of patients had end of therapy serology and hence the percentage reflects this population